Progesterone - Induced blocking factor (PIBF) and Th1/Th 2 cytokine in women with threatened spontaneous abortion

Journal of Perinatal Medicine

Volumn 37, Issue 4, 2009, Pages 338-342

  Hudić, Igor ^a,b   Fatusić, Zlatan ^a  

^a University Clinical Center   (Bosnia and Herzegovina)

^b UNIVERSITY CLINICAL CENTER TUZLA   (Bosnia and Herzegovina)

Author keywords

Anti inflammatory cytokines; Pro inflammatory cytokines; Progesterone induced blocking factor (PIBF); Threatened spontaneous abortion

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; PROGESTERONE INDUCED BLOCKING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BODY FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; IMMINENT ABORTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; TH1 CELL; TH2 CELL; URINE LEVEL;

ABORTION, THREATENED; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY PROTEINS; PROSPECTIVE STUDIES; SUPPRESSOR FACTORS, IMMUNOLOGIC; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 67649923711     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2009.061     Document Type: Article

References (37)

1. Baek H. Aberrant gene expression associated with recurrent pregnancy loss. Mol Hum Reprod. 2004;10:291-7.
2. Chaouat G, Meliani A, Martal J, Raghupathy R, Elliot J, Mosmann T, et al. IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination and local defect in IL-10 production in this abortion-prone combination in corrected by in vivo injection of INF τ. J Immunol. 1995;154:4261-8.
3. Choi BC, Polgar K, Xiao L, Hill JA. Progesteron inhibits in vitro embryotoxic Thl cytokine production to trophoblast in women with recurent pregnancy loss. Hum Reprod. 2000;15(Suppl 1):46-59.
4. Coulam C. Understanding the immunobiology of pregnancy and applying it to treatment of recurrent pregnancy loss. Biology and Medicine. 2000;4:19-29.
5. Dosiou C, Giudice L. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005;26:44-62.
6. Fatušic Z. Imunološki aspekti spontanog i habitualnog pobacaja. Med Arh. 2006;60:129-31.
7. Faust Z, Laš karin G, Rukavina D, Szekeres-Bartho J. Progesterone induced blocking factor inhibits degranulation of NK cells. Am J Reprod Immunol. 1999;42:71-5.
8. Guller S, Wozniak R, Kong L, Lockwood C. Opposing actions of transforming growth factor beta and glucocor-ticoids in the regulation of fibronectin expression in the human placenta. J Clin Endocr Metab. 1995;80:3273-8.
9. Haddad E, Duclos A, Antecka E, Lapp W, Baines M. Role of interferon-gamma in the priming of decidual macro-phages for nitric oxide production and early pregnancy loss. Cell Immnunol. 1997;181:68-75.
10. Haddad E, Duclos A, Lapp W, Baines M. Early embryo loss is associated with the prior expression of macrophage activation markers in the decidua. J Immunol. 1997;158: 4886-92.
11. Hill JA, Anderson D, Polgar K. T helper I-type cellular immunity to trophoblast in women with recurrent abortions. J Am Med Assoc. 1995;273:1933-8.
12. Kalinka J, Szekeres-Bartho J. The impact of dydrogesterone supplementation on hormonal profile and progest-erone-induced blocking factor concentrations in women with threatened abortion. Am J Reprod Immunol. 2005; 53:166-71.
13. Kavalier F. Investigation of recurrent miscarriages. Br Med J. 2005;331:121-2.
14. Kwak-Kim J, Chung-Bang H, Ntrivalas E, Mangubat C, Beaman K, Beer A, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with RPL and in infertile women with multiple implantation failures afted IVF. Hum Reprod. 2003;18:767-73.
15. Letterio J, Roberts A. TGF beta: a critical modulator of immune cell function. Clin Immunol Pathol. 1997;84: 244-50.
16. Palfi M, Jablonowska B, Matthiesen L, Ernerudh J. Circulating interferon-gamma and interleukin-4-secreting cells in recurrent spontaneous abortions. Am J Reprod Immunol. 1999;41:257-63.
17. Parant M. Possible mediators of endotoxin-induced abortions. Res Immunol. 1990;141:164-8.
18. Piccinni MP. Role of T cell in pregnancy. In: Rukavina D, Chaouat G, editors. Embryo implantation: from basics to clinics. Rijeka. University of Rijeka. p. 113-7.
19. Polgar B, Nagy E, Miko E, Varga P, Szekeres-Bartho J. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod. 2004; 71:1699-705.
20. Raghupathy R, Kalinka J. Cytokine imbalance in pregnancy complications and its modulation. Front Biosci. 2008; 1:985-94.
21. Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomised controlled trials. Obstet Gynecol. 2005;105: 273-9.
22. Sedlmayr P. Concepts of feto-maternal tolerance. In: Rukavina D, Chaouat G, editors. Embryo implantation: from basics to clinics. Rijeka: University of Rijeka; 2006. p. 95-102.
23. Sfakianki A, Norwitz M. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med. 2006;19:763-72.
24. Song Y, Keelan J, France J. Activin-A stimulates, while transforming growth factor beta 1 inhibits chorionic gonadotropin production and aromatase activity in cultured human placental trophoblasts. Placenta. 1996;17: 603-10.
25. Stites DP, Bugbee S, Siiteri PK. Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation - relevance to immunosuppression in pregnancy. J Reprod Immunol. 1983;5:215-28.
26. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Totok A, Pacsa AS. The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxiciti: 1. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol. 1985;9:15-9.
27. Szekeres-Bartho J, Kozma N, Halasz M, Polgar B, Milko E, Palkovics T, et al. Immuno-endocrine signals. In: Rukavina D, Chaouat G, editors. Embryo implantation: from basics to clinics. Rijeka. University of Rijeka; 2006. p. 105-7.
28. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G. Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol. 1989;122:281-94.
29. Szekeres-Bartho J, Faust ZS, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effects of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol. 1996;35:348-51.
30. Szekeres-Bartho J, Par G, Dombay Gy, Smart YC, Volgyi Z. The anti-abortive effimice is manifested by modulating NK activity. Cell Immunol. 1997;177:194-9.
31. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achacz I. Progesterone and non-specific immunological mechanisms in pregnancy. Am J Reprod Immunol. 1997;38: 176-82.
32. Szekeres-Bartho J, Szekeres GY, Debre P, Autran B, Chaouat G. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol. 1990;125:273-83.
33. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol. 1996;31:81-95.
34. Szekeres-Bartho J, Wilczynski JR, Basta P, Kalinka J. Role of progesterone and progestin therapy in threatened abortion and preterm labour. Front Biosci. 2008;13:1981-90.
35. Szereday L, Varga P, Szekeres-Bartho J. Cytokine production by lymphocytes in pregnancy. Am J Reprod Immunol. 1997;38:418-22.
36. Wegmann TG, Lin H, Guilbert L, Mossmann TR. Bidirectional cytokine interactions in the maternalfetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today. 1993;1014:353-6.
37. Wolff M, Thaler C, Strowitzki T, Broome J, Stolz W, Tabibzedeh S. Regulated exspression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod. 2000;6:627-34.